A detailed history of Campion Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Campion Asset Management holds 1,900 shares of AMGN stock, worth $609,064. This represents 0.47% of its overall portfolio holdings.

Number of Shares
1,900
Previous 1,900 -0.0%
Holding current value
$609,064
Previous $540,000 9.81%
% of portfolio
0.47%
Previous 0.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $61,066 - $72,210
285 Added 17.65%
1,900 $421,000
Q2 2021

Jul 23, 2021

SELL
$233.58 - $259.14 $158,834 - $176,215
-680 Reduced 29.63%
1,615 $394,000
Q1 2021

Apr 27, 2021

BUY
$221.91 - $258.6 $509,283 - $593,487
2,295 New
2,295 $571,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Campion Asset Management Portfolio

Follow Campion Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campion Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Campion Asset Management with notifications on news.